News

Join the Class Action: Seeking Recovery from TFI International

Join the Class Action: Seeking Recovery from TFI International

Class Action Suit Against TFI International Inc.

Attention, shareholders of TFI International Inc. (NYSE: TFII)! If you purchased shares during a specified period, you may be affected by recent developments regarding the company. There is an ongoing class action lawsuit which you should definitely consider joining to seek potential recovery for losses incurred due to misleading statements made by the company.

Important Information for Shareholders

Shareholders who bought shares of TFI International Inc. from April 26, 2024, to February 19, 2025, are encouraged to take action. It's vital to reach out as there is an opportunity to possibly become a lead plaintiff in this case. Importantly, participating in the recovery process does not require being appointed as a lead plaintiff.

Allegations in the Lawsuit

The allegations center around claims that during the class period, TFI International Inc. and its representatives made several materially false and misleading statements. These statements failed to disclose critical information regarding the company's operations. Specifically, it was noted that: (1) the company was losing customers among small to medium businesses; (2) there was a notable decline in TForce revenue; (3) TFI was facing challenges in managing its operational costs; (4) these issues contributed to declining profitability in one of its primary business segments; and (5) positive statements made by management lacked a reasonable basis, ultimately misleading investors.

Upcoming Deadlines

Time is of the essence! The deadline to register for this class action lawsuit is May 13, 2025. It is crucial for shareholders to not hesitate in submitting their information to be included in the proceedings. If you believe you are eligible, please ensure you register before the deadline to secure your rights.

Next Steps for Interested Shareholders

Once you register, you will be included in a portfolio monitoring service that will provide continual updates related to this legal proceeding. Moreover, wishing to be a lead plaintiff carries no financial obligation, making this opportunity even more accessible for shareholders.

Why the Gross Law Firm?

The Gross Law Firm stands out as a nationally recognized class action firm, dedicated to protecting investor rights. Their mission focuses on addressing issues of deceit, fraud, and illegal business practices that lead to investor losses. The firm advocates for accountability among corporations, ensuring they maintain ethical practices while contributing positively to the market. Trust in a legal representative that has a history of seeking recovery on behalf of investors who suffered losses due to misleading company information.

Company Contact Information

For any further inquiries or if you require assistance regarding your potential involvement in this class action, you can reach out to The Gross Law Firm, located at:

15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (646) 453-8903

Frequently Asked Questions

What is the class action lawsuit about?

The lawsuit addresses allegations that TFI International issued misleading statements that negatively impacted shareholders.

Who can join the class action?

Any shareholder who purchased shares of TFI International Inc. during the specified period is eligible to join.

What is the deadline to register?

The deadline to register for the class action is May 13, 2025.

Is there a cost to participate?

No, there is no cost to participate in this class action lawsuit.

How will I receive updates about the case?

Once registered, you will be enrolled in a monitoring service that keeps you updated on the case status.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading

Top 5 Most Recently Viewed Articles

Plus Therapeutics Advances with REYOBIQ™ in Clinical Trial Results

Updated Category News Views 142

Plus Therapeutics Showcases Clinical Advances in REYOBIQ™ Houston-based Plus Therapeutics, Inc. (NASDAQ: PSTV) recently presented its promising results from the ReSPECT-LM clinical trial, specifically focusing on the treatment of patients with leptomeningeal metastases (LM). This presentation was made by the trial's principal investigator during the notable SNO/ASCO CNS...

Continue Reading
Investors Eye Domo's Earnings Report with Anticipation

Updated Category News Views 95

Domo Earnings Report Overview Domo (NASDAQ: DOMO) is preparing to announce its quarterly earnings, and anticipation is building among investors. This release is particularly significant as the market eagerly awaits insights into the company’s fiscal health and future guidance. What Analysts Expect Analysts predict that Domo will report an earnings per share (EPS) of...

Continue Reading
Analyzing Haleon PLC's Recent Market Performance Trends

Updated Category News Views 106

Understanding Recent Trends in Haleon PLC Stock Haleon PLC (NYSE: HLN) has recently seen a notable increase in its short interest, which has grown by 10.34% since the last report. Currently, there are approximately 14.34 million shares sold short, comprising around 0.32% of all the available shares for trading. The Significance of Short Interest But what does this short...

Continue Reading
Energy Price Trends Amid Political Promises for 2024

Updated Category News Views 202

Examining the Effects of Political Promises on Energy Prices As the upcoming election approaches, politicians are making strong promises focused on energy. Former President Donald Trump is pushing for a "drill, baby, drill" strategy to help reduce energy prices, while Vice President Kamala Harris is prioritizing her commitment to fracking. Looking Ahead: Energy Trends...

Continue Reading
Rob Conti Elevated to CIO of First Watch Restaurant Group

Updated Category News Views 195

First Watch Appoints Rob Conti as Chief Information Officer First Watch Restaurant Group, Inc. (NASDAQ: FWRG), a prominent name in daytime dining, has made a notable leadership change by promoting Rob Conti to the position of Chief Information Officer. Since joining the company in 2019, Conti has been a vital part of the team, having previously held the role of Senior...

Continue Reading